Skip to main content

Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.

Objective

INPACT aims at the pre-clinical development of innovative drugs and drug formulations against selected cancers (eg prostate cancer) and pathogenic bacteria (eg S. aureus). The INPACT consortium allies the expertise of both academic and industrial R&D partners that contribute with their own unique technologies to achieve new drugs that are only possible to develop in an integrative effort. Academic partners have unique knowledge and technologies on supercharged viral proteins-derived cell-penetrating peptides (eg from Dengue virus) and ultra-resistant cyclic peptides that may be transferred to the industrial partners, which in turn have specialized proprietary technologies on anticancer and/or peptide drugs’ technologies. The judicious exchange of knowledge among partners will lead to new resistant peptides for trans-barrier delivery of drugs (eg cyclic peptide-drug chimeras) and bacterial killing (both planktonic and biofilms). INPACT includes four leading academic partners (from Portugal, Spain, Australia, and Brazil) and three consolidated biotech SMEs (one from Portugal and two Spain).
In addition to the R&D project itself, INPACT involves at the highest possible level a top business school in Europe (IESE, Barcelona, Spain), a consolidated media partner specialised in science communication (Ciencia Hoje, Rio de Janeiro, Brazil) and experts in international science funding from one of the top US universities (University of Stanford). The consortium will be the perfect environment for young researchers to acquire knowledge and skills in science, technology, entrepreneurship, business, and communication so they can pro-actively tailor their career path in a life-long learning perspective. This is a contribution towards the advancement of Europe through the use of research and education for societal development and economic growth.

Field of science

  • /medical and health sciences/health sciences/infectious disease/RNA virus
  • /social sciences/economics and business
  • /medical and health sciences/clinical medicine/oncology/cancer
  • /medical and health sciences/clinical medicine/oncology/cancer/prostate cancer

Call for proposal

H2020-MSCA-RISE-2014
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Address
Avenida Prof Egas Moniz
1649 028 Lisboa
Portugal
Activity type
Research Organisations
EU contribution
€ 463 500

Participants (5)

UNIVERSIDAD POMPEU FABRA
Spain
EU contribution
€ 180 000
Address
Placa De La Merce, 10-12
08002 Barcelona
Activity type
Higher or Secondary Education Establishments
UNIVERSIDAD DE NAVARRA
Spain
EU contribution
€ 49 500
Address
Campus Universitario Edificio Central
31080 Pamplona
Activity type
Higher or Secondary Education Establishments
TECHNOPHAGE INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA SA
Portugal
EU contribution
€ 40 500
Address
Avenida Professor Egas Moniz Edificio Egas Moniz Piso 2 Sala A8
1649 028 Lisboa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
CENTRO ATLANTICO DEL MEDICAMENTO, SA
Spain
EU contribution
€ 45 000
Address
Avda Trinidad 61 La S/n Planta 7 Aulario Torre Prof Agustin Arevalo
38204 San Cristobal De La Laguna Tenerife
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
PROTEODESIGN SL
Spain
EU contribution
€ 72 000
Address
Baldiri Reixac 10-12
08028 Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partners (4)

BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
United States
Address
Serra Mall 450
94305 2004 Stanford
Activity type
Higher or Secondary Education Establishments
UNIVERSIDADE FEDERAL DO RIO DE JANEIRO
Brazil
Address
Av Brigadeiro Trompowski Sn 2
21941 590 Rio De Janeiro
Activity type
Higher or Secondary Education Establishments
THE UNIVERSITY OF QUEENSLAND
Australia
Address
St Lucia
4072 Brisbane
Activity type
Higher or Secondary Education Establishments
INSTITUTO CIENCIA HOJE-ICH
Brazil
Address
Av Venceslau Bras 71 Casa 27 E Pavi Lhao Ma Botafogo
22290 140 Rio De Janeiro
Activity type
Other